Literature DB >> 14745326

Correlation between preoperative serum concentration of type IV collagen 7s domain and hepatic failure following resection of hepatocellular carcinoma.

Shoji Kubo1, Tadashi Tsukamoto, Kazuhiro Hirohashi, Hiromu Tanaka, Taichi Shuto, Shigekazu Takemura, Takatsugu Yamamoto, Takahiro Uenishi, Masao Ogawa, Hiroaki Kinoshita.   

Abstract

OBJECTIVE: To determine the predictive value of the preoperative serum concentration of type IV collagen 7s domain (7s collagen) for postoperative hepatic failure in patients undergoing liver resection for hepatocellular carcinoma. SUMMARY BACKGROUND DATA: Clear and reliable criteria for predicting hepatic failure after liver resection are needed. The serum 7s collagen concentration correlates with the histologic degree of active hepatitis and hepatic fibrosis and may predict the regenerative potential of the liver.
METHODS: Potential risk factors for postoperative hepatic failure, including the serum 7s collagen concentration, were evaluated in 251 patients who underwent liver resection for hepatocellular carcinoma. Prognostic significance was determined by univariate and multivariate analyses.
RESULTS: Hepatic failure developed postoperatively in 25 patients, 4 of whom died. The serum 7s collagen concentration correlated with the histologic degree of hepatitis activity and hepatic fibrosis. The serum 7s collagen concentration was a risk factor for postoperative hepatic failure by univariate analysis and was the only risk factor on multivariate analysis. No patient with a serum 7s collagen concentration <12 ng/mL died of postoperative hepatic failure, and all 4 patients who died had a serum 7s collagen concentration >or=12 ng/mL.
CONCLUSIONS: The preoperative serum 7s collagen concentration correlated independently with hepatic failure following liver resection for hepatocellular carcinoma. Patients whose serum 7s collagen is >or=12 ng/mL are poor candidates for hepatic resection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14745326      PMCID: PMC1356211          DOI: 10.1097/01.sla.0000109152.48425.4d

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  45 in total

1.  Significance of serum type IV collagen level of hepatectomized patients with chronic liver damage.

Authors:  Yasuyuki Shimahara; Naritaka Yamamoto; Naoki Uyama; Hiroaki Okuyama; Hirohito Momoi; Tatsuhiko Kamikawa; Hiroaki Terajima; Yuji Iimuro; Yuzo Yamamoto; Iwao Ikai; Fumiki Kushihata; Hidenori Kiyochi; Nobuaki Kobayashi; Yoshio Yamaoka
Journal:  World J Surg       Date:  2002-02-04       Impact factor: 3.352

2.  Liver regeneration and restoration of liver function after partial hepatectomy: the relation of fibrosis of the liver parenchyma.

Authors:  S Miyazaki; K Takasaki; M Yamamoto; M Tsugita; T Otsubo
Journal:  Hepatogastroenterology       Date:  1999 Sep-Oct

Review 3.  Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective.

Authors:  Ronnie Tung-Ping Poon; Sheung-Tat Fan; Flora Hau-Fung Tsang; John Wong
Journal:  Ann Surg       Date:  2002-04       Impact factor: 12.969

4.  Analysis of 100 consecutive hepatectomies: risk factors in patients with liver cirrhosis or obstructive jaundice.

Authors:  B C Das; S Isaji; Y Kawarada
Journal:  World J Surg       Date:  2001-03       Impact factor: 3.352

5.  Use of technetium 99m diethylenetriamine-pentaacetic acid-galactosyl-human serum albumin liver scintigraphy in the evaluation of preoperative and postoperative hepatic functional reserve for hepatectomy.

Authors:  A H Kwon; S K Ha-Kawa; S Uetsuji; Y Kamiyama; Y Tanaka
Journal:  Surgery       Date:  1995-04       Impact factor: 3.982

6.  Hepatic resection for hepatocellular carcinoma. An audit of 343 patients.

Authors:  E C Lai; S T Fan; C M Lo; K M Chu; C L Liu; J Wong
Journal:  Ann Surg       Date:  1995-03       Impact factor: 12.969

7.  Limited hepatic resection effective for selected cirrhotic patients with primary liver cancer.

Authors:  T Kanematsu; K Takenaka; T Matsumata; T Furuta; K Sugimachi; K Inokuchi
Journal:  Ann Surg       Date:  1984-01       Impact factor: 12.969

8.  Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis.

Authors:  R G Knodell; K G Ishak; W C Black; T S Chen; R Craig; N Kaplowitz; T W Kiernan; J Wollman
Journal:  Hepatology       Date:  1981 Sep-Oct       Impact factor: 17.425

9.  Criteria for safe hepatic resection.

Authors:  S Miyagawa; M Makuuchi; S Kawasaki; T Kakazu
Journal:  Am J Surg       Date:  1995-06       Impact factor: 2.565

10.  Impaired liver function and long-term prognosis after hepatectomy for hepatocellular carcinoma.

Authors:  M Yasui; A Harada; A Torii; A Nakao; T Nonami; H Takagi
Journal:  World J Surg       Date:  1995 May-Jun       Impact factor: 3.352

View more
  9 in total

1.  Safety of hepatic resection for hepatocellular carcinoma in obese patients with cirrhosis.

Authors:  Shogo Tanaka; Yuji Iimuro; Tadamichi Hirano; Seikan Hai; Kazuhiro Suzumura; Ikuo Nakamura; Yuichi Kondo; Jiro Fujimoto
Journal:  Surg Today       Date:  2013-08-31       Impact factor: 2.549

Review 2.  Hepatocellular carcinoma: therapy and prevention.

Authors:  Hubert E Blum
Journal:  World J Gastroenterol       Date:  2005-12-21       Impact factor: 5.742

Review 3.  Defining Post Hepatectomy Liver Insufficiency: Where do We stand?

Authors:  Kelly Lafaro; Stefan Buettner; Hadia Maqsood; Doris Wagner; Fabio Bagante; Gaya Spolverato; Li Xu; Ihab Kamel; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2015-06-11       Impact factor: 3.452

4.  Liver failure after hepatocellular carcinoma surgery.

Authors:  Hiroaki Motoyama; Akira Kobayashi; Takahide Yokoyama; Akira Shimizu; Norihiko Furusawa; Hiroshi Sakai; Noriyuki Kitagawa; Yohei Ohkubo; Teruomi Tsukahara; Shin-ichi Miyagawa
Journal:  Langenbecks Arch Surg       Date:  2014-10-22       Impact factor: 3.445

5.  Remnant liver volume-based predictors of postoperative liver dysfunction after hepatectomy: analysis of 625 consecutive patients from a single institution.

Authors:  Hirohisa Okabe; Toru Beppu; Akira Chikamoto; Hiromitsu Hayashi; Morikatsu Yoshida; Toshiro Masuda; Katsunori Imai; Kosuke Mima; Shigeki Nakagawa; Hideyuki Kuroki; Hidetoshi Nitta; Takatoshi Ishiko; Daisuke Hashimoto; Yasuyuki Yamashita; Hideo Baba
Journal:  Int J Clin Oncol       Date:  2013-07-17       Impact factor: 3.402

6.  Impact of laparoscopic liver resection for hepatocellular carcinoma with F4-liver cirrhosis.

Authors:  Akishige Kanazawa; Tadashi Tsukamoto; Sadatoshi Shimizu; Shintaro Kodai; Sadaaki Yamazoe; Satoshi Yamamoto; Shoji Kubo
Journal:  Surg Endosc       Date:  2013-02-08       Impact factor: 4.584

7.  Thioacetamide-induced hepatic fibrosis in the common marmoset.

Authors:  Takashi Inoue; Yukihito Ishizaka; Emi Sasaki; Jun Lu; Takayuki Mineshige; Mikio Yanase; Erika Sasaki; Masayuki Shimoda
Journal:  Exp Anim       Date:  2018-03-22

Review 8.  Assessment of Preoperative Liver Function for Surgical Decision Making in Patients with Hepatocellular Carcinoma.

Authors:  Takashi Kokudo; Kiyoshi Hasegawa; Chikara Shirata; Meguri Tanimoto; Takeaki Ishizawa; Junichi Kaneko; Nobuhisa Akamatsu; Junichi Arita; Nicolas Demartines; Emilie Uldry; Norihiro Kokudo; Nermin Halkic
Journal:  Liver Cancer       Date:  2019-07-26       Impact factor: 11.740

9.  Extracellular matrix specific protein fingerprints measured in serum can separate pancreatic cancer patients from healthy controls.

Authors:  Nicholas Willumsen; Cecilie L Bager; Diana J Leeming; Victoria Smith; Morten A Karsdal; David Dornan; Anne-Christine Bay-Jensen
Journal:  BMC Cancer       Date:  2013-11-21       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.